{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:23Z","timestamp":1783448303871,"version":"3.55.0"},"reference-count":31,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":165,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Medullary thyroid carcinoma (MTC) constitutes 5\u201310% of thyroid malignancies but accounts for 15% of thyroid cancer-related mortality. Twenty percent of MTC are hereditary and are part of familial MTC or multiple endocrine neoplasia (MEN) syndromes. Classical MTC presents as a nodular goiter with or without lymphadenopathy, or occasionally diarrhea and metastatic symptoms. Several patients in our cohort had unusual features that delayed diagnosis. The standard management remains surgical resection, with tyrosine kinase inhibitors (TKIs) in RET mutation-positive or RET mutation-negative metastatic cases and\/or Lutathera peptide receptor radionuclide therapy (PRRT) used in disseminated disease, and external beam radiotherapy for locally aggressive or infiltrative retaining a limited role. However, some patients developed therapy-related complications or exhibited resistance to treatment. Of the 80 MTC patients reviewed, this case series highlights 10 atypical presentations in nine cases : 3 unusual tumors along with MTC, namely chondrosarcoma, carcinoma prostrate, and ectopic Cushing\u2019s syndrome; 4 unusual associations or presenting manifestations: pneumoconiosis masquerading as lung metastasis, Marfanoid habitus in MEN-2A and VHL spectrum disease, 1 with skull metastasis, and 2 cases with TKI-related complications in the form of glomerulonephritis and one patient displayed Marfanoid habitus with a RET mutation but without MEN2B or fibrillin gene mutation, while another developed bowel perforation secondary to lenvatinib therapy emphasizing diagnostic and therapeutic challenges and rare tumor associations. This series underscores the heterogeneity of MTC and the need for thorough evaluation and personalized management. Greater clinician awareness of MTC\u2019s diverse presentations is essential to improve early diagnosis and optimize treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1530\/edm-25-0098","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:46:50Z","timestamp":1769096810000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":0,"title":["Atypical presentation and association of medullary thyroid carcinoma: reports from a tertiary care center in Northwest India"],"prefix":"10.1530","volume":"2026","author":[{"given":"Ananda Mohan","family":"Chakraborty","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaditya","family":"Ghosh","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Das","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajender","family":"Kumar","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Nahar","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-3033","authenticated-orcid":true,"given":"Sanja","family":"Medenica","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Rai","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-1611","authenticated-orcid":true,"given":"Pinaki","family":"Dutta","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026070713563104100_bib1","first-page":"50","article-title":"Medullary thyroid cancer \u2013 feature review and update on systemic treatment","volume":"59","author":"Dabeli\u0107","year":"2020","journal-title":"Acta Clin Croat"},{"key":"2026070713563104100_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2265.2008.03229.x","article-title":"Long-term prognosis of medullary thyroid carcinoma","volume":"69","author":"Rendl","year":"2008","journal-title":"Clin Endocrinol"},{"key":"2026070713563104100_bib3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s11845-021-02886-8","article-title":"Surgical aspects and controversies in the management of medullary thyroid cancer","volume":"191","author":"Green","year":"2022","journal-title":"Ir J Med Sci"},{"key":"2026070713563104100_bib4","first-page":"P425","article-title":"RET mutation negative familial medullary thyroid carcinoma: four families and literature review","volume":"34","author":"Iacovazzo","year":"2014","journal-title":"Endocr Abstr"},{"key":"2026070713563104100_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1226348","article-title":"An audit of medullary thyroid carcinoma from a tertiary care hospital in Northwest India","volume":"14","author":"Chakraborty","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026070713563104100_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2024-262801","article-title":"Malignant thyroid neoplasm with ectopic Cushing\u2019s syndrome","volume":"17","author":"Jha","year":"2024","journal-title":"BMJ Case Rep"},{"key":"2026070713563104100_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221110698","article-title":"Management of medullary carcinoma of the thyroid: a review","volume":"50","author":"Jayasinghe","year":"2022","journal-title":"J Int Med Res"},{"key":"2026070713563104100_bib8","first-page":"52","article-title":"Outcome of treatment for medullary thyroid carcinoma-a single centre experience","volume":"9","author":"Cherian","year":"2018","journal-title":"Indian J Surgoncol"},{"key":"2026070713563104100_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/ijem.ijem_474_21","article-title":"Medullary thyroid cancer: an experience from a tertiary care hospital of a developing country","volume":"26","author":"Khan","year":"2022","journal-title":"Indian J Endocrinolmetab"},{"key":"2026070713563104100_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"key":"2026070713563104100_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"2026070713563104100_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017588","article-title":"Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: a retrospective study","volume":"98","author":"Iwasaki","year":"2019","journal-title":"Medicine"},{"key":"2026070713563104100_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1681\/ASN.20213210S1575a","article-title":"Kidney pathology findings in patients with AKI associated with tyrosine kinase inhibitors","volume":"32","author":"Mukku","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026070713563104100_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cen.14617","article-title":"Medullary thyroid cancer with ectopic Cushing\u2019s syndrome: a multicentre case series","volume":"96","author":"Koehler","year":"2022","journal-title":"Clin Endocrinol"},{"key":"2026070713563104100_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/genes10090698","article-title":"Twenty-five years experience on RET genetic screening on hereditary MTC: an update on the prevalence of germline RET mutations","volume":"10","author":"Elisei","year":"2019","journal-title":"Genes"},{"key":"2026070713563104100_bib16","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/jc.2002-021422","article-title":"RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome","volume":"88","author":"Pu\u00f1ales","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713563104100_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0377-1237(09)80103-2","article-title":"Scalp metastases from thyroid carcinoma","volume":"65","author":"Mukherjee","year":"2009","journal-title":"Med J Armed Forces India"},{"key":"2026070713563104100_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0973-0354.159529","article-title":"Scalp metastasis from follicular thyroid carcinoma diagnosed by fine needle aspiration cytology: a case series","volume":"13","author":"Kumar","year":"2016","journal-title":"Thyroid Res Pract"},{"key":"2026070713563104100_bib19","doi-asserted-by":"crossref","first-page":"T29","DOI":"10.1530\/ERC-17-0209","article-title":"A comprehensive review on MEN2B","volume":"25","author":"Castinetti","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026070713563104100_bib20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12020-024-03809-0","article-title":"Disease-free survival and the prognostic factors affecting disease-free survival in patients with medullary thyroid carcinoma: a multicenter cohort study","volume":"85","author":"Zuhur","year":"2024","journal-title":"Endocrine"},{"key":"2026070713563104100_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MOU.0000000000000994","article-title":"Prevalence and trends of urolithiasis among adults","volume":"32","author":"Abufaraj","year":"2022","journal-title":"Curr Opin Urol"},{"key":"2026070713563104100_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"2026070713563104100_bib23","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan\u2019s syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"2026070713563104100_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.109549","article-title":"Dissection of RET p.M918T-driven progression of hereditary vs. sporadic medullary thyroid cancer","volume":"51","author":"Machens","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"2026070713563104100_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3803\/EnM.2021.1082","article-title":"Current guidelines for management of medullary thyroid carcinoma","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab"},{"key":"2026070713563104100_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000525569","article-title":"Bowel perforation in a patient with hepatocellular carcinoma during lenvatinib treatment","volume":"16","author":"Mizokami","year":"2022","journal-title":"Case Rep Gastroenterol"},{"key":"2026070713563104100_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10637-017-0522-4","article-title":"Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancer","volume":"36","author":"Date","year":"2018","journal-title":"Invest New Drugs"},{"key":"2026070713563104100_bib28","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","article-title":"ATM mutations in cancer: therapeutic implications","volume":"15","author":"Choi","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2026070713563104100_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J Clin Oncol"},{"key":"2026070713563104100_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e34032","article-title":"Ubiquitin-modifying enzymes in thyroid cancer: mechanisms and functions","volume":"10","author":"Xiong","year":"2024","journal-title":"Heliyon"},{"key":"2026070713563104100_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2019.03.033","article-title":"The role of external beam radiotherapy in the management of medullary carcinoma of the thyroid: a systematic review","volume":"136","author":"Rowell","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2026\/1\/EDM-25-0098.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2026\/1\/EDM-25-0098.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/edm\/article-pdf\/doi\/10.1530\/EDM-25-0098\/505080\/edm-25-0098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/edm\/article-pdf\/doi\/10.1530\/EDM-25-0098\/505080\/edm-25-0098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:57:28Z","timestamp":1783447048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/edm\/article\/2026\/1\/EDM250098\/75450\/Atypical-presentation-and-association-of-medullary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/edm-25-0098","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"EDM250098"}}